Review
Aug 2026
Bifidobacterium and the gut-immune axis: Mechanistic insights and therapeutic potential.
Preclinical and clinical evidence suggests potential benefits in antibiotic-associated dysbiosis, inflammatory bowel disease, cancer therapy response, early life immune maturation, and selected metabolic and neuroimmune disorders, although the outcomes remain heterogeneous.
A. Ramesh, R. Subbarayan, Rupendra SHRESTHA et al.
· Microbiology Research · 0 citations